Chicago, March 24, 2022 (GLOBE NEWSWIRE) -- According to Arizton research report, increasing prevalence of infertility, rising number of fertility clinics, changing lifestyle of people leading to infertility, increasing acceptance of ART procedure are some of the factors driving the U.S. assisted reproductive technology (ART) market growth during the forecast period.
Other factors include growing number of ART device manufacturing companies, high investments by private & public players, and increasing financial assistance programs are also contributing to the growth of overall assisted reproductive technology market.
Assisted Reproductive Technology (ART) Market Report Scope
REPORT ATTRIBUTES | DETAILS |
MARKET SIZE (2027) | $4.5 Billion |
CAGR (2022-2027) | 7% (2022-2027) |
BASE YEAR | 2021 |
FORECAST YEAR | 2022-2027 |
MARKET SEGMENT BY TYPE | Services (Source (Frozen Non-Donor, Fresh Non-Donor, Fresh Donor, and Frozen Donor) |
MARKET SEGMENT BY AGE GROUP | Between 35 & 40 Years, Less Than 35 Years and Above 40 Years |
MARKET SEGMENT BY TECHNIQUE | In Virto Fertilization (IVF), Frozen Embryo Transfer (FET), and Others) |
MARKET SEGMENT BY DEVICES | Product (Consumables, Media, and Equipment) |
MARKET SEGMENT BY END-USER | Fertility Clinics and Hospitals |
GRAPHICAL ANALYSIS | U.S. |
Click Here to Download the Free Sample Report
Increasing Acceptance of Art Procedures
The growing popularity of single women opting for motherhood through organizations such as Single Mothers by Choice and Choice Mom is fueling the demand for ARTs. The increasing awareness regarding the availability of ARTs, their success rate, and their benefits, especially in developing economies, is also increasing the demand for ARTs. For instance, the aggressive marketing strategies of fertility clinics, availability of flexible payment options, and increase in digital marketing of fertility services by private fertility centers are driving positive awareness of the fertility industry and its services.
Key Offerings:
- Market Size & Forecast by Revenue | 2021−2027
- Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by type, age group, technique, and devices
- Competitive Landscape – 6 key vendors and 8 other prominent manufacturers, and 38 prominent ART service providers are profiled in the report
Rising Venture Capital & Private Equity Investments In Infertility Services
The entry of venture capitalists and private equity is renovating the overall fertility services industry. Some are spending on advertising and a deliberate strategy of reaching out to married working women who are not yet trying to conceive. New investors are uncovering the attractiveness of infertility treatment after seeing the success of recent investments and establishing fertility clinics with sophisticated infrastructure.
For Free Sample click: https://www.arizton.com/request-sample/3276
U.S. Assisted Reproductive Technology (AT) Market Segmentation Analysis
Segmentation by Type
- Services
- Source
- Frozen Non-Donor
- Fresh Non-Donor
- Fresh Donor
- Frozen Donor
- Source
Segmentation by Age Group
- Between 35 & 40 Years
- Less Than 35 Years
- Above 40 Years
Segmentation by Technique
- In Virto Fertilization (IVF)
- Frozen Embryo Transfer (FET)
- Others
Segmentation by Devices
- Product
- Consumables
- Media
- Equipment
- End-user
- Fertility Clinics
- Hospitals
U.S. Assisted Reproductive Technology (ART) Market Vendor Insights
The key vendors in the market include the Cooper companies, Cook Medical, FUJIFILM Irvine Scientific, Hamilton Throne, Merck KGaA, and Vitrolife. With the rising demand for infertility treatment in the US, the market share of these vendors is expected to grow in the coming years. However, the major players are facing stiff competition from emerging players. Also, major players are forming strategic alliances by entering into co-marketing agreements to increase their competitiveness and penetration in the U.S. assisted reproductive technology (ART) market.
Other prominent vendors include Carl Zeiss, Esco Lifesciences, Gynemed, Kitazato USA, Nidacon, Rocket Medical, Thermo Fisher Scientific, and Thomas Medical. These vendors compete by providing affordable ART devices to fertility clinics and hospitals. Although key players dominate the market and other players are also focusing on delivering low-cost ART solutions to their customers. Vendors are aggressively aiming to introduce innovative devices to penetrate and utilize the huge growth potential prevailing in the market. The technological advancements and innovations in the field of ART is providing tremendous growth opportunity to the vendors.
Click Here to Download the Free Sample Report
Read some of the top-selling reports:
- Infertility Treatment Market - Global Outlook and Forecast 2019-2024
- U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026
- Fertility Test Market - Global Outlook & Forecast 2022-2027
- U.S. Fertility Test Market - Industry Outlook & Forecast 2022-2027
About Arizton:
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Call: +1-312-235-2040
+1 302 469 0707